The role of ADCC effector function in the anti-tumor efficacy of anti-EGFR antibodies in a mouse xenograft model.

被引：0
|
作者：
Lo, KM [1 ]
Lan, Y [1 ]
Zhang, X [1 ]
Gillies, SD [1 ]
机构：
[1] EMD Lexigen Res Ctr, Billerica, MA USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6099S / 6099S
页数：1
相关论文
共 50 条
  • [41] Role of homeostatic MHC class I recognition in regulating anti-tumor effector function of NK cells
    He, Ka
    Yamamae, Yui
    Sasaki, Soichiro
    Tahara, Hideaki
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 1163 - 1163
  • [42] Immuno-regulatory role of PP2A on anti-tumor effector function of NK cells
    Yamamae, Yui
    Kawada, Manabu
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2022, 113
  • [43] Monoclonal antibodies to desmoglein 3 exhibit in vivo anti-tumor efficacy
    Kawai, Shigeto
    Nakano, Kiyotaka
    Ito, Hirotaka
    Funahashi, Shin-ichi
    Yoshida, Kenji
    Kimura, Naoki
    Sakumoto, Hirofumi
    Nishizawa, Takashi
    Adachi, Kenji
    Fujii, Etsuko
    Hirata, Yuichi
    Ishikawa, Shumpei
    Aburatani, Hiroyuki
    CANCER RESEARCH, 2009, 69
  • [44] Inhibition of RANKL enhances the anti-tumor effects of the EGFr inhibitor panitumumab in a mouse model of bone metastasis
    Canon, J.
    Bryant, R.
    Roudier, M.
    Osgood, T.
    Jones, J.
    Miller, R.
    Coxon, A.
    Radinsky, R.
    Dougall, W.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 35 - 36
  • [45] Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models
    Matsuo T.
    Nishizuka S.S.
    Ishida K.
    Iwaya T.
    Ikeda M.
    Wakabayashi G.
    BMC Research Notes, 4 (1)
  • [46] Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors
    Li, Guanjie
    Ohishi, Tomokazu
    Kaneko, Mika K.
    Takei, Junko
    Mizuno, Takuya
    Kawada, Manabu
    Saito, Masaki
    Suzuki, Hiroyuki
    Kato, Yukinari
    CELLS, 2021, 10 (12)
  • [47] Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models
    Jia, Dianlong
    Yang, Yujiao
    Yuan, Fengjiao
    Fan, Qing
    Wang, Feifei
    Huang, Yujiao
    Song, Hao
    Hu, Ping
    Wang, Rui
    Li, Guangyong
    Liu, Renmin
    Li, Jun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 586
  • [48] The effect of protein phosphatase inhibitor on NK cell anti-tumor effector function
    Yamamae, Yui
    Miyazato, Kiho
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2021, 112 : 729 - 729
  • [49] Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
    Xianhua Wu
    Jingchuan Zhang
    Ruheng Zhen
    Jing Lv
    Li Zheng
    Xinying Su
    Guanshan Zhu
    Paul R Gavine
    Songtao Xu
    Shaohua Lu
    Jun Hou
    Yalan Liu
    Chen Xu
    Yunshan Tan
    Liang Xie
    Xiaolu Yin
    Deming He
    Qunsheng Ji
    Yingyong Hou
    Di Ge
    Journal of Translational Medicine, 10
  • [50] Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
    Wu, Xianhua
    Zhang, Jingchuan
    Zhen, Ruheng
    Lv, Jing
    Zheng, Li
    Su, Xinying
    Zhu, Guanshan
    Gavine, Paul R.
    Xu, Songtao
    Lu, Shaohua
    Hou, Jun
    Liu, Yalan
    Xu, Chen
    Tan, Yunshan
    Xie, Liang
    Yin, Xiaolu
    He, Deming
    Ji, Qunsheng
    Hou, Yingyong
    Ge, Di
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
12345